Cargando…
Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran
BACKGROUND: Health decision makers need to know the impact of the development of a new intervention on the public health and health care costs so that they can plan for economic and financial objectives. The aim of this study was to determine the budget impact of adding Haemophilus influenzae type b...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237530/ https://www.ncbi.nlm.nih.gov/pubmed/28088246 http://dx.doi.org/10.1186/s40199-017-0166-0 |
_version_ | 1782495545159319552 |
---|---|
author | Teimouri, Fatemeh Kebriaeezadeh, Abbas Zahraei, Seyed Mohsen Gheiratian, MohammadMahdi Nikfar, Shekoufeh |
author_facet | Teimouri, Fatemeh Kebriaeezadeh, Abbas Zahraei, Seyed Mohsen Gheiratian, MohammadMahdi Nikfar, Shekoufeh |
author_sort | Teimouri, Fatemeh |
collection | PubMed |
description | BACKGROUND: Health decision makers need to know the impact of the development of a new intervention on the public health and health care costs so that they can plan for economic and financial objectives. The aim of this study was to determine the budget impact of adding Haemophilus influenzae type b (Hib) as a part of a Pentavalent vaccine (Hib-HBV-DTP) to the national childhood immunization schedule of Iran. METHODS: An excel-based model was developed to determine the costs of including the Pentavalent vaccine in the national immunization program (NIP), comparing the present schedule with the previous one (including separate DTP and hepatitis B vaccines). The total annual costs included the cost of vaccination (the vaccine and syringe) and the cost of Hib treatment. The health outcome was the estimated annual cases of the diseases. The net budget impact was the difference in the total annual cost between the two schedules. Uncertainty about the vaccine effectiveness, vaccination coverage, cost of the vaccine, and cost of the diseases were handled through scenario analysis. RESULTS: The total cost of vaccination during 5 years was $18,060,463 in the previous program and $67,774,786 in the present program. Inclusion of the Pentavalent vaccine would increase the vaccination cost about $49 million, but would save approximately $6 million in the healthcare costs due to reduction of disease cases and treatment costs. The introduction of the Pentavalent vaccine resulted in a net increase in the healthcare budget expenditure across all scenarios from $43.4 million to $50.7 million. CONCLUSIONS: The results of this study showed that the inclusion of the Pentavalent vaccine in the NIP of Iran had a significant impact on the health care budget and increased the financial burden on the government. GRAPHICAL ABSTRACT: Budget impact of including Pentavalent vaccine in the national immunization schedule of Iranᅟ [Image: see text] |
format | Online Article Text |
id | pubmed-5237530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52375302017-01-18 Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran Teimouri, Fatemeh Kebriaeezadeh, Abbas Zahraei, Seyed Mohsen Gheiratian, MohammadMahdi Nikfar, Shekoufeh Daru Research Article BACKGROUND: Health decision makers need to know the impact of the development of a new intervention on the public health and health care costs so that they can plan for economic and financial objectives. The aim of this study was to determine the budget impact of adding Haemophilus influenzae type b (Hib) as a part of a Pentavalent vaccine (Hib-HBV-DTP) to the national childhood immunization schedule of Iran. METHODS: An excel-based model was developed to determine the costs of including the Pentavalent vaccine in the national immunization program (NIP), comparing the present schedule with the previous one (including separate DTP and hepatitis B vaccines). The total annual costs included the cost of vaccination (the vaccine and syringe) and the cost of Hib treatment. The health outcome was the estimated annual cases of the diseases. The net budget impact was the difference in the total annual cost between the two schedules. Uncertainty about the vaccine effectiveness, vaccination coverage, cost of the vaccine, and cost of the diseases were handled through scenario analysis. RESULTS: The total cost of vaccination during 5 years was $18,060,463 in the previous program and $67,774,786 in the present program. Inclusion of the Pentavalent vaccine would increase the vaccination cost about $49 million, but would save approximately $6 million in the healthcare costs due to reduction of disease cases and treatment costs. The introduction of the Pentavalent vaccine resulted in a net increase in the healthcare budget expenditure across all scenarios from $43.4 million to $50.7 million. CONCLUSIONS: The results of this study showed that the inclusion of the Pentavalent vaccine in the NIP of Iran had a significant impact on the health care budget and increased the financial burden on the government. GRAPHICAL ABSTRACT: Budget impact of including Pentavalent vaccine in the national immunization schedule of Iranᅟ [Image: see text] BioMed Central 2017-01-14 /pmc/articles/PMC5237530/ /pubmed/28088246 http://dx.doi.org/10.1186/s40199-017-0166-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Teimouri, Fatemeh Kebriaeezadeh, Abbas Zahraei, Seyed Mohsen Gheiratian, MohammadMahdi Nikfar, Shekoufeh Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran |
title | Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran |
title_full | Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran |
title_fullStr | Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran |
title_full_unstemmed | Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran |
title_short | Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran |
title_sort | budget impact analysis of vaccination against haemophilus influenzae type b as a part of a pentavalent vaccine in the childhood immunization schedule of iran |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237530/ https://www.ncbi.nlm.nih.gov/pubmed/28088246 http://dx.doi.org/10.1186/s40199-017-0166-0 |
work_keys_str_mv | AT teimourifatemeh budgetimpactanalysisofvaccinationagainsthaemophilusinfluenzaetypebasapartofapentavalentvaccineinthechildhoodimmunizationscheduleofiran AT kebriaeezadehabbas budgetimpactanalysisofvaccinationagainsthaemophilusinfluenzaetypebasapartofapentavalentvaccineinthechildhoodimmunizationscheduleofiran AT zahraeiseyedmohsen budgetimpactanalysisofvaccinationagainsthaemophilusinfluenzaetypebasapartofapentavalentvaccineinthechildhoodimmunizationscheduleofiran AT gheiratianmohammadmahdi budgetimpactanalysisofvaccinationagainsthaemophilusinfluenzaetypebasapartofapentavalentvaccineinthechildhoodimmunizationscheduleofiran AT nikfarshekoufeh budgetimpactanalysisofvaccinationagainsthaemophilusinfluenzaetypebasapartofapentavalentvaccineinthechildhoodimmunizationscheduleofiran |